Hepatic transarterial chemoembolization and retroperitoneal lymph node radiofrequency ablation in the multidisciplinary approach of an overt metastatic leiomyosarcoma

5Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Metastatic leiomyosarcoma has a dismal prognosis, and therapy mainly consists of palliative systemic chemotherapy. A selected subgroup of patients with limited metastatic disease may eventually derive benefit from more aggressive strategies, including resection of isolated metastasis. We report here the successful use of hepatic transarterial chemoembolization and retroperitoneal lymph node radiofrequency ablation in a patient with advanced leiomyosarcoma metastatic to the liver and retroperitoneum. © 2013 International Cancer Imaging Society.

Cite

CITATION STYLE

APA

De Lima Araujo, L. H., Gouveia, H. R., De Queiroz Freitas, E., Pedras, F. V., & Luz, J. H. M. (2013). Hepatic transarterial chemoembolization and retroperitoneal lymph node radiofrequency ablation in the multidisciplinary approach of an overt metastatic leiomyosarcoma. Cancer Imaging, 13(1), 123–127. https://doi.org/10.1102/1470-7330.2013.0014

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free